These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27346187)

  • 21. Plausibility in patent law: an unsettled concept.
    Crawford C; Reynolds L
    Pharm Pat Anal; 2016 Sep; 5(5):289-93. PubMed ID: 27573248
    [No Abstract]   [Full Text] [Related]  

  • 22. Patent issues in drug development: perspectives of a pharmaceutical scientist-attorney.
    Melethil S
    AAPS J; 2005 Oct; 7(3):E723-8. PubMed ID: 16353948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed WTO ruling on generic drug development.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced scope for extension of patent term for pharmaceuticals under Australian law.
    Lyons M; Stark A
    Pharm Pat Anal; 2015; 4(5):351-5. PubMed ID: 26490425
    [No Abstract]   [Full Text] [Related]  

  • 25. Incorporating a right to health perspective into the resolution of patent law disputes.
    Oke EK
    Health Hum Rights; 2013 Dec; 15(2):97-109. PubMed ID: 24421172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical patents and some international trade issues: Canada, the United States, and NAFTA.
    Tancer RS
    Clin Ther; 1993; 15(6):1177-84; discussion 1120. PubMed ID: 8111813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The skilled person: an evolving concept.
    Cohen L; Davies C
    Pharm Pat Anal; 2013 Nov; 2(6):725-35. PubMed ID: 24237238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canadian court upholds Glaxo's patent on AZT.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2001; 6(1-2):53-7. PubMed ID: 11837029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent protection in Europe of pharmaceuticals found to have a further medical indication.
    Cockbain J
    Pharm Pat Anal; 2012 Mar; 1(1):17-8. PubMed ID: 24236708
    [No Abstract]   [Full Text] [Related]  

  • 30. Health policy or intellectual property policy? The fight over Bill C-91. Canadian Healthcare Association.
    Int J Health Care Qual Assur Inc Leadersh Health Serv; 1997; 10(2-3):vii-x. PubMed ID: 10169229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patent owner options for correcting errors in US patents after grant.
    Armstrong M
    Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonobviousness of pharmaceutical inventions: implications for patent prosecution and litigation.
    Dhulap S; Kulkarni M
    Pharm Pat Anal; 2019 Jul; 8(4):91-107. PubMed ID: 31414965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 34. Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States.
    Son KB; Lopert R; Gleeson D; Lee TJ
    Global Health; 2018 Oct; 14(1):101. PubMed ID: 30355313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 36. The new follow-on-biologics law: a section by section analysis of the patent litigation provisions in the Biologics Price Competition and Innovation Act of 2009.
    Dougherty MP
    Food Drug Law J; 2010; 65(2):231-45, i. PubMed ID: 24475541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How would patent reform legislation in the United States impact the pharmaceutical industry?
    Williams AW
    Expert Opin Ther Pat; 2015 Feb; 25(2):131-3. PubMed ID: 25387953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The patent-regulatory regime in Canada.
    Pei NP; Hamilton JS
    Pharm Pat Anal; 2012 Nov; 1(5):525-8. PubMed ID: 24236920
    [No Abstract]   [Full Text] [Related]  

  • 40. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
    Treasure CL; Kesselheim AS
    JAMA Intern Med; 2016 Jun; 176(6):729-30. PubMed ID: 27183456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.